Skip to main content
. Author manuscript; available in PMC: 2022 Jul 18.
Published in final edited form as: Clin Cancer Res. 2019 Jul 30;25(20):6107–6118. doi: 10.1158/1078-0432.CCR-18-3341

Figure 1:

Figure 1:

Overview of Findings

a) Number of HCC confirmed cases with alterations detected through cfDNA.

b) Total number of alterations identified among the 181 patients with alterations, and the proportion of alteration types identified.

c) Action ability among mutations identified.

d) Total number of actionable alterations, after removing silent, VUS, and non-actionable mutations.